Status:
COMPLETED
Jet Lidocaine for Pain Relief During Needle Insertion in a Pediatric Emergency Department
Lead Sponsor:
NYU Langone Health
Conditions:
Pain
Eligibility:
All Genders
5-19 years
Phase:
NA
Brief Summary
The purpose of this study is to explore to what degree, if any, Jet lidocaine will reduce or alleviate pain, as compared to Jet normal saline, in children undergoing needle insertion in the Pediatric ...
Detailed Description
This randomized clinical trial involves double blind allocation of either (1) Jet administration of buffered 1% lidocaine or (2) Jet normal saline (placebo) prior to needle insertion in the PED. The p...
Eligibility Criteria
Inclusion
- Age 5 - 18 years
- Evaluation and treatment requiring needle insertion in \<60 minutes (Patient is not a candidate for EMLA cream)
- Parent or patient consent, and child assent
Exclusion
- Age \<5 years or \>18 years
- Children eligible for or receiving EMLA cream
- Significant blunt or penetrating trauma requiring rapid evaluation/resuscitation (GCS\<15)
- Unstable shock
- Altered sensorium or intoxication
- History of allergy to Lidocaine
- Neurologic deficit involving a lack of sensation in area of insertion
- Developmental delay so as not to understand pain scale
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00681902
Start Date
March 1 2007
End Date
July 1 2008
Last Update
February 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bellevue Hospital
New York, New York, United States, 10016